ICU Medical Inc

Healthcare · Medical Instruments & Supplies

159.70$ -1.0% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Income Statement

ICU Medical Inc (ICUI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 552 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ICUI
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	97	96	248	332	343	370	372	360	327	340	331	312	307	316	329	303	319	320	318	322	336	341	543	561	598	578	569	549	553	588	567	596	589	630	605	549	537	540	530	552	2,159
Cost of Revenue	46	45	159	243	232	233	223	209	193	206	196	208	189	201	207	197	205	201	205	198	208	213	374	393	411	403	377	357	369	416	381	389	384	403	395	341	336	338	357	317	1,348
Gross Profit	51	51	89	88	112	137	149	152	135	135	135	104	119	114	121	106	114	120	113	124	128	127	169	168	186	175	192	192	184	172	185	207	205	227	210	208	201	202	173	235	811
Research & Development	3.7	2.7	12	13	13	14	13	14	13	14	13	11	12	13	11	10	10	12	11	11	12	13	24	23	23	23	20	22	21	22	22	23	21	22	23	22	21	21	21	23	86
Selling, General & Administrative	22	23	65	85	77	77	87	84	78	80	73	68	66	71	72	67	71	74	72	74	75	81	153	159	149	143	152	151	149	155	158	160	163	159	157	159	153	156	155	152	615
Total Operating Expenses	26	25	77	98	90	91	100	97	91	93	88	80	78	96	95	87	88	93	86	89	89	104	211	168	187	175	183	190	161	184	196	200	197	190	197	197	187	177	142	196	702
Operating Income	22	14	-17	-36	-3.7	42	2.9	30	0.8	-12	30	26	33	18	26	20	26	27	27	34	38	24	-42	0.0	-0.5	-0.2	9.4	2.8	23	-12	-11	7.7	8.2	38	13	11	14	25	31	39	109
Interest Expense	0.1	0.2	0.5	0.5	0.7	0.3	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.2	0.8	0.6	0.2	0.2	0.2	0.2	0.4	14	16	21	20	24	26	26	27	26	27	27	26	29	23	20	25	20	19	83
Pre-Tax Income	23	14	46	-39	4.7	40	3.8	30	1.4	-12	33	28	33	21	20	21	26	30	27	35	38	23	-55	-17	-21	-21	-13	-23	-5.4	-37	-37	-20	-18	8.2	-11	37	-4.1	-18	-4.6	23	-3.9
Income Tax Expense	4.2	4.6	-10	-2.1	4.6	-9.8	-1.1	-1.5	1.2	-5.1	2.4	4.8	6.2	0.3	3.5	1.9	1.2	4.0	3.4	6.4	6.8	3.4	-17	-9.4	-8.1	-5.9	-3.6	-13	-13	-20	2.7	1.9	15	32	4.6	1.2	-0.7	-2.7	-35	7.1	-31
Net Income	19	9.5	56	-37	0.1	50	4.9	31	0.2	-7.4	31	23	27	21	17	19	25	26	24	28	31	20	-38	-7.5	-13	-16	-9.8	-9.9	7.2	-17	-39	-21	-33	-24	-15	35	-3.4	-16	30	19	30
EBITDA	30	30	24	-20	40	132	70	74	64	7.3	69	51	54	43	44	45	44	54	49	57	60	47	12	66	58	55	67	60	285	47	45	62	65	87	64	106	67	61	29	141	298

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings